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Abstract: Immunocontraceptive vaccines have shown some promise for fertility control of
white-tailed deer (Odocoileus virginianus) in urban and suburban habitats where traditional
methods of population control may not be applicable. Currently, the only contraceptive
vaccine approved by the U.S. Environmental Protection Agency for use in white-tailed deer
is GonaConTM Immunocontraceptive Vaccine, but it is registered for use via hand-injection
only. It has been suggested that remote-delivery of immunocontraceptives would be more
cost-effective than hand-injection, but there is the potential for incomplete injection from a
syringe-dart. Therefore, the purpose of our research was to: (1) conduct a dart configuration
assessment trial to determine the ideal syringe-dart configuration for remote-delivery of
GonaCon to white-tailed deer and (2) use the determined syringe-dart configuration in a
subsequent trial to evaluate the vaccine efficacy when administered to female white-tailed
deer via hand-injection versus syringe-dart. We saw comparable results with regard to
vaccine dispersal during the dart configuration assessment and the efficacy trial; syringedart injected deer presented vaccine deposits and reaction sites both subcutaneously and
intramuscularly, whereas, hand-injected deer presented vaccine deposits and reaction sites
only intramuscularly. One year after administration, 4 of 5 deer treated with syringe-darts
were pregnant, compared to 3 of 6 deer that received hand-injections. Anti-GnRH titers were
negatively related to pregnancy status. We did not observe a high level of vaccine efficacy
with the syringe-dart delivery method we used. Therefore, we recommend further research of
syringe-dart delivery of GonaCon with a larger sample size where the vaccine is deployed in
a single bolus similar to a hand-injected presentation.
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Dense populations of white-tailed deer
(Odocoileus virginianus) coupled with urban
and suburban expansion have led to increased
human–deer interactions. When negative, these
interactions often result in significant economic
losses resulting from deer–vehicle collisions
(DVCs), tick-borne pathogens, and landscape
damage (DeNicola et al. 2000).
DeNicola and Williams (2008) demonstrated
that reducing local deer densities can
significantly reduce DVCs. Lowering deer
densities may also reduce the incidence of Lyme
disease, because there is a positive correlation
between white-tailed deer and blacklegged tick
(Ixodes scapularis) abundance (Stafford 2004,
Kilpatrick et al. 2014). The recommended deer
density for the reduction of blacklegged ticks
and associated occurrences of Lyme disease

is <8 deer/km2 (Rand et al. 2003). Low deer
densities may also reduce damage to personal
property such as landscaping and gardens
(DeNicola et al. 2000).
Historically, lethal removal methods (i.e.,
sharpshooting, hunting, or trap and euthanasia)
have been the accepted action of management
for deer population reduction (Williams et al.
2013). However, when suburban communities
are faced with the need to lower deer densities,
nonlethal control options are often preferred
because of legality, safety concerns, and
social attitudes related to lethal management
(McCullough et al. 1997). The primary methods
for nonlethal reduction of deer populations are
translocation and fertility control. Translocated
deer have low survival rates due to capture
myopathy, DVCs, and losses to hunters (Óbryan
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and McCullough 1985, Jones and
Witham 1990). Even if survival rates
were increased, relocating deer is
usually not an option because of
both cost and legal issues concerning
the spread of pathogens (Conover
2002).
Among
nonsurgical
fertility
methods of control, immunocontraceptive vaccines have shown
the most promise (Massei and Cowan
2014). Treatments with porcine
zona pellucida (PZP) vaccines have
reduced deer densities (Rutberg
et al. 2013a, b). However, PZP is
not registered for use in deer, and
it allows females to have repeated
estrous cycles, which may cause
more males to move into females’
home ranges, potentially leading to
TM
increases in DVCs and damage to Figure 1. One year after the administering GonaCon , deer
were euthanized by sharpshooting.
ornamental plantings (Boulanger
et al. 2012, 2014). Deer may also suffer deer management ideally should be deliverable
physiological stress as a result of the extended remotely (Rutberg et al. 2013b). The purpose
breeding season caused by PZP, (Killian and of our research was to: (1) conduct a dart
configuration assessment trial to determine
Miller 2000).
GonaConTM is the only immunocontraceptive the ideal syringe-dart configuration for
vaccine registered by the U.S. Environmental remote-delivery of GonaCon to white-tailed
Protection Agency (EPA) for use in deer, and deer and (2) use the determined syringe-dart
its labeling requires administration by hand- configuration in a subsequent trial to evaluate
injection (EPA Reg. No. 56228-40). Unlike the vaccine efficacy when administered to
PZP, GonaCon suppresses the secretion of female white-tailed deer via hand-injection
reproductive hormones, thus, preventing versus syringe-dart.
female deer from ovulating or coming into
estrus (Miller et al. 2004). GonaCon in singleMethods
shot form was shown to be 88% and 47% effective Study area
during the first and second years, respectively,
This study was conducted on a 176-ha
in female white-tailed deer (Gionfriddo et al. property in southern Connecticut consisting
2009). Treatment of female deer with GonaCon of upland deciduous forest with a thick
via hand-injection causes no adverse effects on understory, wetlands, and open fields. The
mobility or general health of deer. The only property is enclosed by a 3-m-high chain-link
adverse reactions documented in female deer fence with 5-cm mesh and surrounded by
have been intramuscular injection-site lesions urban development. The deer on the site are
(Gionfriddo et al. 2011).
privately-managed, not exposed to hunting,
The cost of reducing population densities and habituated to human presence. There are
through fertility control, with current delivery no individual pens or confinement areas, deer
methods, is high (Massei and Cowan 2014). on site are free to range within the fence, and no
As currently approved, hand-injection of supplemental feeding regimes are present. Over
GonaCon requires the live capture of each the past 5 years pregnancy rates of untreated
deer prior to treatment with the vaccine. adult females have ranged from 92 to 95%, and
It has been suggested that an effective the population has fluctuated between 30 and
immunocontraceptive for urban and suburban 50 individuals.
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Dart configuration
assessment
Two adult males and adult
female deer were captured
under a drop net (Conner et
al. 1987) and anesthetized by
injection of Telazol® (4.4 mg/
kg) and xylazine hydrochloride
(2.2 mg/kg). Each deer received
an injection of GonaCon in both
hamstrings and quadriceps
(4 injections per deer). Ten
of the 12 injections were
administered remotely, with
the deer perpendicular to the
darter, from a distance of 5 m
using a gas-based dart projector
(Figure 1). The syringe-dart
configurations consisted of 2-cc
and 1.5-cc, rapid and slow-inject
(1/3-sec) syringe-darts with
Figure 2. Captured deer were randomly assigned to 1 of 2 treatment
3.18-cm and 2.54-cm barbless, groups. One group was administered GonaConTM via hand-injection,
tri-port needles (Pneu-Dart and the other group received GonaCon via syringe-dart delivery.
Inc., Williamsport, Penn.). We
included the larger volume syringe-darts Services, National Wildlife Research Center,
in the trial to assess whether vaccine dose Quality Assurance Protocol-QA-2075.
suitable for a larger mammal (e.g., horse [Equus
Vaccination. Captured deer were randomly
caballus]) could be delivered remotely. Two of assigned to 1 of 2 treatment groups. One group
the 12 injections were administered via hand- was administered GonaCon (1.5 cc) via handinjection with 1.5-cc syringes equipped with injection with 1.5-cc syringes equipped with
a 2.5-cm and 3.8-cm needle. While still under 3.81-cm needles administered intramuscularly
anesthesia, each deer was euthanized with a to the upper hind limb via hand-injection
gunshot to the center of the brain. Hind limbs (Figure 2). The other group while under
were then dissected to reveal the distribution of anesthesia received the same dose administered
the vaccine deposits (GonaCon is a white and by a 1.5 cc slow-inject syringe-dart with a 3.18viscous vaccine, enabling visual examination of cm barbless, tri-port needle. Deer were darted
distribution).
with a gas-based dart projector from a distance
of 5-m with the deer perpendicular to the
Vaccine efficacy trial
darter. All darts were examined to determine
Capture. Adult (≥1.5 years) female white-tailed if the entire volume of GonaCon was expelled
deer were captured using drop-nets during February from the dart upon impact. After treatment, the
and March 2013. Deer were anesthetized by injection reversal agent tolazoline hydrochloride (2.0 mg/
of Telazol® (4.4 mg/kg) and xylazine hydrochloride kg IV) was administered and the individuals
(2.2 mg/kg) and aged using tooth replacement and were visually monitored for complications
wear (Severinghaus 1949). Each deer was fitted with recovery. One year later, deer were located
with ear tags (Destron Fearing, St. Paul, Minn.) and euthanized by sharpshooting techniques as
and a VHF radio-collar (Advanced Telemetry described in DeNicola et al. (1997).
Anti-GnRH
antibody
titers.
Serum
Systems, Isanti, Minn.) to facilitate locating the
concentrations
of
anti-GnRH
antibodies
can
individual for euthanasia 1 year after capture. All
be
used
to
estimate
immunocontraceptive
deer capture and handling was approved by the
Institutional Animal Care and Use Committee efficacy (Miller et al. 2008). Blood samples
and U.S. Department of Agriculture, Wildlife were collected via cardiac puncture within 1
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Table 1. Trial data for vaccine deposit results in white-tailed deer with varied inject rates and
needle lengths of syringe-darts with barbless, tri-port needles and hand-inject syringes.
Injection

Volume (cc)

Needle (cm)

Dart retention

Vaccine deposita

Slow-inject dart

2.0

3.18

Retained

VM, VWC

Slow-inject dart

2.0

3.18

Retained

VM, VWC

Slow-inject dart

2.0

3.18

Retained

VM, VWC

Slow-inject dart

2.0

3.18

Bounced

VM, VWC, VG

Slow-inject dart

1.5

3.18

Bounced

VM, VWC, VG

Slow-inject dart

1.5

3.18

Retained

VM, VWC

Slow-inject dart

1.5

2.54

Bounced

VM, VWC, VG

Slow-inject dart

1.5

2.54

Bounced

VM, VWC, VG

Rapid-inject dart

2.0

3.18

Bounced

VM, VWC, VG

Rapid-inject dart

2.0

3.18

Retained

VM, VWC

Hand-inject syringe

1.5

2.54

N/A

VM

Hand-inject syringe

1.5

3.81

N/A

VM

a

VM = vaccine in muscle depth. VWC = vaccine in wound channel; VG = substantial vaccine on
ground.

minute after death. Serum was isolated via
centrifugation and then frozen and shipped
to the National Wildlife Research Center
(NWRC) in Fort Collins, Colorado. Antibody
titers were measured using enzyme-linked
immunosorbent assays as previously described
(Miller et al. 2008).
Necropsy. Hind limbs containing the injection
site were examined externally for abscesses.
We then necropsied each deer to permit
internal examination. Presence or absence of
granulomatous nodules and sterile abscesses
at the injection site were noted. Presence or
absence of fetuses were recorded to assess
pregnancy rates and forehead-rump lengths
(FRL) were measured on fetuses to determine
fetal age in days as previously described
(Hamilton et al. 1985).
Statistical analysis. All statistical analyses
were performed using R version 3.1.2 (R Core
Team, Vienna, Austria, 2015) and significance
level was set at α = 0.05. We used Fisher’s exact
test to assess differences between the 2 treatment
groups in the proportion of deer pregnant. We
then used the Wilcoxon signed-rank test to
assess if there was a significant difference in
titer levels between the 2 treatment groups to
assess any difference in titer levels between
pregnant and nonpregnant deer, regardless of
treatment group.

Results

Dart configuration assessment

The syringe-darts with 3.18-cm needles
were retained in the deer frequently, whereas
the 2.54-cm needles bounced out upon impact
(Table 1). However, the 3.18-cm needles did not
retain on 3 occasions. With each dart-injection
site, there was a substantial amount of vaccine
that travelled back up the wound channel
depositing subcutaneously; vaccine left in the
musculature was dispersed in fascia between
muscles. Syringe-darts that were not retained
in the deer deposited most of the vaccine on the
ground with only a minimal amount deposited
in the muscle. Hand-injection deposited the
vaccine in a single bolus in the muscle at the
depth of the needle.

Vaccine efficacy trial
Thirteen female deer were captured under
drop nets from February 22 through March 3,
2013, and treated with the GonaCon vaccine. Six
females received the vaccine via syringe-dart
(all darts were retained in the deer) and seven
via hand-injection (Table 2). Eleven of these
13 females were euthanized during February
2014. We were unable to locate 1 female due to
transmitter failure, and the skeletal remains of
the other were found during telemetry-assisted
searches.
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Table 2. Treatment data for white-tailed deer in the hand-inject versus dart-delivery GonaConTM trial,
treated February 22 - March 3, 2013 and euthanized for necropsy February 2014.
Treatment
group

a

Tag number

Age (years) Titer level Lactating
2013
2013

Pregnant
2014a

Injection site reactiona

Hand

34R/9L

2

1:128,000

Yes

1 fetus

Concentrated IM

Hand

181/181

7

1:128,000

Yes

NP

Slightly dispersed IM

Hand

8R/7L

7

1:128,000

Yes

NP

Concentrated IM

Hand

47R/48L

4

1:64,000

Yes

NP

Concentrated IM

Hand

42R/37L

5

1:2,000

Yes

1 fetus

Slightly dispersed IM

Hand

43R/44L

9

0

Yes

1 fetus

Concentrated IM

Hand

55R/20L

7

–

–

TF

Dart

41R/40L

6

1:128,000

Yes

NP

Dart

19R/21L

8

1:8,000

Yes

1 fetus

Small subcutaneous—
concentrated IM

Dart

32R/33L

2

0

Yes

1 fetus

Small subcutaneous
—dispersed IM

Dart

35R/36L

6

0

Yes

2 fetuses

Subcutaneous—small
IM

Dart

18R/17L

2

0

Yes

2 fetuses

Small subcutaneous—
dispersed IM

Dart

50R/52L

8

–

–

–
Subcutaneous—
dispersed IM

MS

–

IM = intramuscular; NP = not pregnant; TF = transmitter failure; MS = mortality signal.

Four of 5 deer treated with syringe-darts were
pregnant at the time of euthanasia, compared to
3 of 6 deer that received hand-injections (Table
2). There was no significant difference between
treatment groups in proportion pregnant (P
= 0.54). Two of the females that were treated
with syringe-darts had twins. The remaining
pregnant females contained a single fetus.
Conception was estimated to have occurred
during the typical November peak breeding
season, with the exception of 1 female in the
syringe-dart treatment group that conceived
mid-January.
Injection-site
reactions
ranged
from
concentrated intramuscular granulomas to
dispersed intramuscular and subcutaneous
granulomas. Only vaccines administered via
syringe-dart caused subcutaneous injection site
reactions; hand-injection caused intramuscular
reactions only (Table 2). Hand-injection
reactions resulted in concentrated granulomas
and abscess masses, with the exception of two,
which resulted in dispersed intramuscular
granulomas.
There was no difference in titer levels between
treatment groups (P = 0.21). However, titer

levels were strongly correlated with pregnancy
status. There was a significant difference in
titer levels between pregnant and nonpregnant
deer regardless of treatment group (P = 0.02).
One individual (female #34/9) with an elevated
titer contained a single fetus (Table 2). All
other individuals with titers ≥1:64,000 were not
pregnant; deer with titers <1:10,000 all were
pregnant.

Discussion

We found that the efficacy of GonaCon 1-year
post-administration was less than reported by
Miller et al. (2008), Gionfriddo et al. (2009),
and Gionfriddo et al. (2011). This may be
related to the timing of vaccine delivery. In
the aforementioned trials, deer were treated
in July and August (2 to 4 months prior to the
breeding season), whereas females in our trial
were treated in February and March (8 months
prior to the breeding season), which may have
resulted in reduced titer levels at the time of the
breeding season.
We saw comparable results with regards
to vaccine dispersal during the initial dart
configuration assessment and the efficacy trial.
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In both trials, the syringe-dart resulted in a
substantial amount of vaccine traveling back
up the wound channel while hand-injections
resulted in the vaccine deposited in a single
bolus. In general, the hand-injection reaction
sites had a larger concentrated granuloma and
abscess confined within the muscle, whereas
the syringe-dart injection sites displayed a
more dispersed granuloma in the muscle plus
some subcutaneous reaction areas. Gionfriddo
et al. (2011) suggested that the formation
of granulomas at injection sites may be an
essential aspect of a strong immune response
that induces infertility in GonaCon-treated
animals. From our observations, the body can
better compartmentalize the dispersed vaccine
resulting in small granulomas and may reduce
immune response. The larger bolus deposit of
the hand-injected vaccine resulted in localized
granulomas and abscesses that likely extend the
exposure of the vaccine to the immune system,
thus, increasing the efficacy. The significant
difference in antibody titer between pregnant
and nonpregnant animals supports the findings
by Miller et al. (2000) of a titer level ≥1:64,000
is sufficient to suppress fertility in white-tailed
deer.

Management implications

Given the performance of the vaccine
coupled with remote-injection, we question
whether syringe-dart delivery of GonaCon
is an appropriate management tool at this
time. The lack of a statistically significant
difference in contraceptive efficacy between
the 2 treatments may be due to a small sample
size. We recommend further research on the
development of this technique with a larger
sample size. GonaCon may perform better
when hand-injected as a single bolus, limiting
the dispersion of the vaccine and amount exiting
the wound channel. Research should include
the use of different needle barbing and porting
techniques, such as various configurations of
gelatin-barbs and 3.8-cm, tri-port needles. The
gelatin-barb and longer needle will more likely
ensure complete delivery of the vaccine into the
deep musculature of the individual similar to
hand-injection. A gelatin-barb, smaller than the
conventional size, may be adequate for singlebolus injection without compromising dart
recovery. We recommend using 2.0-cc darts

so that an additional 0.5 cc per required dose
may be administered to compensate for the
vaccine that may travel out the wound channel.
This design will need to be accompanied by a
slow injection rate (e.g., 1 second) for a more
controlled vaccine deposit, similar to a handinjection. Future trials should be conducted
with similar timing to our trial (January
through March) to further test the vaccine
efficacy when administered during optimal
months for capture and darting (i.e., when bait
leverage is high and there is no foliage on trees
to compromise darting opportunities).
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